US Patent Issued to Akebia Therapeutics on Sept. 23 for "Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonylamino}acetic acid, compositions, and uses thereof" (American, Canadian Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,877, issued on Sept. 23, was assigned to Akebia Therapeutics Inc. (Cambridge, Mass.).

"Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonylamino}acetic acid, compositions, and uses thereof" was invented by James Densmore Copp (Silverthorne, Colo.), Ann W. Newman (Lafayette, Ind.) and Anne Luong (Mississauga, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are solid forms comprising {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions comprising the solid forms, methods of making the solid forms and methods of their use for the treatment of various diseases and/or disorders."

The patent...